Univest
Univest
  • Markets

Morepen Laboratories (MOREPENLAB) Share Price hits fresh 52-week high; stock trades at Rs 149.95

  • September 1, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Morepen Laboratories Share Price
Morepen Laboratories Ltd. (MOREPENLAB) share price reached a fresh 52-week high of Rs 150.75 today and later stood at Rs 149.95, up 4.31% from the previous close. Market cap was Rs 7,413.81 crore.

Morepen Laboratories Share Price is in focus after the stock touched a fresh 52-week high of Rs 150.75 and last traded at Rs 149.95, up Rs 6.20 or 4.31% from the previous close of Rs 143.75. The company’s market capitalisation stands at Rs 7,413.81 crore, placing today’s move in a clear market-cap context for Morepen Laboratories Share Price watchers. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. In the first part of the session, Morepen Laboratories Share Price moved between Rs 145.15 and Rs 150.75 after opening at Rs 145.80. For readers tracking Morepen Laboratories Share Price Today, the key point is straightforward: the stock is trading at a fresh yearly high, while the verified data stops short of assigning a reason.

Univest data also shows that Morepen Laboratories Share Price is being read alongside valuation and fundamentals rather than a fresh corporate announcement. That makes Morepen Laboratories Share Price News relevant for investors who want a factual view of the move, the company’s market cap, and how the stock compares with sector and peer benchmarks. Morepen Laboratories Share Price therefore matters today not because of a stated trigger, but because the price action, 52-week high and fundamental metrics are all visible at once.

Table of Contents

Toggle
  • Morepen Laboratories Share Price Today: Price Action Analysis
  • Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Morepen Laboratories
  • About Morepen Laboratories
  • Frequently Asked Questions
    • What is Morepen Laboratories Share Price today?
    • What is the fresh 52-week high for Morepen Laboratories Share Price?
    • How much did Morepen Laboratories Share Price move today?
    • What is the market capitalisation of Morepen Laboratories?
    • How is Morepen Laboratories Share Price valued on earnings?
    • How does Morepen Laboratories Share Price compare on book value?
    • What do ROE and ROCE show for Morepen Laboratories Share Price?
    • What revenue figure is relevant for Morepen Laboratories Share Price?
  • Track Morepen Laboratories Share Price on Univest

Morepen Laboratories Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 149.95
Previous Close Rs 143.75
Today's Move +Rs 6.2 (+4.31%)
Open Rs 145.8
High Rs 150.75
Low Rs 145.15
Market Capitalisation Rs 7,413.81 crore

Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 149.95 versus the previous close of Rs 143.75, a rise of 4.31%. The stock opened at Rs 145.8, reached a high of Rs 150.75 and touched a low of Rs 145.15.

Morepen Laboratories Share Price Today shows a simple intraday pattern: the stock opened at Rs 145.80, traded as low as Rs 145.15, touched Rs 150.75, and last stood at Rs 149.95. The gain of Rs 6.20 from the previous close of Rs 143.75 equals 4.31%, and the fresh 52-week high of Rs 150.75 was also the day’s top. For Morepen Laboratories Share Price, that means the current quote is only slightly below the day high while remaining firmly above the previous close. According to latest Univest figures, the event is price-led and the verified numbers do not establish a separate catalyst. For readers scanning Morepen Laboratories Share Price Live updates, the relevant facts are the open, low, high and current trade, because they frame the day’s range clearly.

Morepen Laboratories Share Price has therefore moved into a yearly high zone within the session itself. Morepen Laboratories Share Price Today also sits alongside the company’s Rs 7,413.81 crore market cap, which helps place the move in scale. Morepen Laboratories Share Price News is important here because it captures a fresh 52-week high without turning it into an all-time high claim. The next layer of analysis is valuation, because the price action alone does not explain how the stock is priced relative to its healthcare peers.

Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 7,413.81 crore
P/E Ratio 56.05x
P/B Ratio 6.05x
ROE 7.96%
ROCE 10.19%
EPS Rs 2.56
Book Value Per Share Rs 23.78
Dividend Yield 0.14%

Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 56.05x, P/B 6.05x, ROE 7.96%, ROCE 10.19%. Read together, these ratios describe the company’s position rather than a recommendation.

Morepen Laboratories Ltd. has a market capitalisation of Rs 7,413.81 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 56.05x, P/B at 6.05x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.86x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 56.05x
Benchmark Median P/E 31.86x
Benchmark Average P/E 48.41x
Benchmark P/E Range 3.58x to 695.67x
Company P/B Ratio 6.05x
Benchmark Median P/B 2.93x
Company ROE 7.96%
Benchmark Median ROE 11.78%
Company ROCE 10.19%
Benchmark Median ROCE 13.65%
Company Market Capitalisation Rs 7,413.81 crore
Benchmark Median Market Cap Rs 789.87 crore

Morepen Laboratories Ltd. (MOREPENLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 56.05x, which is above the benchmark median of 31.86x, a difference of +75.93%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.78%, a difference of -32.43%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.65%, a difference of -25.35%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Supriya Lifescience Ltd. SUPRIYA 7,364.58 37.12 6.03 19.06 25.3
SYMBIOTEC PHARMALAB LTD SYMBIOTEC 7,507.04 67.23 4.93 11.22 12.41
Bliss GVS Pharma Ltd. BLISSGVS 7,022.6 52.32 5.78 12.11 17.4
Sanofi India Ltd. SANOFI 6,967.45 21.7 8.51 44.5 55.46
Innova Captab Ltd. INNOVACAP 6,553.11 41.8 5.76 13.75 15.04

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 56.05x compared with the displayed peer median of 41.8x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 7.96% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 7,413.81 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Morepen Laboratories

  • Morepen Laboratories Share Price touched a fresh 52-week high of Rs 150.75 and last traded at Rs 149.95.
  • Morepen Laboratories Share Price is up Rs 6.20, or 4.31%, from the previous close of Rs 143.75.
  • Morepen Laboratories Share Price carries a market capitalisation of Rs 7,413.81 crore.
  • Morepen Laboratories Share Price trades at a P/E of 56.05 and a P/B of 6.05.
  • Morepen Laboratories Share Price shows ROE of 7.96% and ROCE of 10.19% versus the sector benchmark medians.

About Morepen Laboratories

Morepen Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Morepen Laboratories Share Price is being tracked by investors who follow the company’s listed equity on NSE and BSE. In the latest reported quarter, revenue for Jun 2026 stood at Rs 570.13 crore. Morepen Laboratories Share Price also reflects the company’s EPS of 2.56, book value of Rs 23.78 and dividend yield of 0.14%. For a company overview, Morepen Laboratories Share Price is best understood through its sector classification, quarterly revenue and valuation ratios rather than through assumptions beyond the verified facts.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Morepen Laboratories Share Price today?

Ans. Morepen Laboratories Share Price is Rs 149.95, up 4.31% from the previous close of Rs 143.75. The stock also touched a fresh 52-week high of Rs 150.75 during the session.

What is the fresh 52-week high for Morepen Laboratories Share Price?

Ans. Morepen Laboratories Share Price touched a fresh 52-week high of Rs 150.75. The current quote of Rs 149.95 remains just below that level as the session continues. The stock moved 4.31% so far today.

How much did Morepen Laboratories Share Price move today?

Ans. Morepen Laboratories Share Price moved up Rs 6.20, which is 4.31%, versus the previous close. The opening level was Rs 145.80 and the day low was Rs 145.15.

What is the market capitalisation of Morepen Laboratories?

Ans. Morepen Laboratories Share Price is backed by a market capitalisation of Rs 7,413.81 crore. That places it above the same-industry median market cap of Rs 789.87 crore in the benchmark set.

How is Morepen Laboratories Share Price valued on earnings?

Ans. Morepen Laboratories Share Price trades at a P/E ratio of 56.05. Its EPS is 2.56, so the price is being assessed against a relatively modest earnings-per-share base. The stock moved 4.31% so far today.

How does Morepen Laboratories Share Price compare on book value?

Ans. Morepen Laboratories Share Price has a P/B ratio of 6.05 and a book value of Rs 23.78. That places it above the industry median P/B of 2.93 in the benchmark group.

What do ROE and ROCE show for Morepen Laboratories Share Price?

Ans. Morepen Laboratories Share Price shows ROE of 7.96% and ROCE of 10.19%. Both are below the benchmark medians of 11.78% and 13.65% in the same-industry comparison set. The stock moved 4.31% so far today.

What revenue figure is relevant for Morepen Laboratories Share Price?

Ans. The latest reported quarterly revenue for Morepen Laboratories Share Price was Rs 570.13 crore for Jun 2026. That figure provides period-specific operating context alongside the stock’s valuation ratios.

Track Morepen Laboratories Share Price on Univest

Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Morepen Laboratories Share Price on Univest for live price updates, 52-week levels, valuation ratios, market capitalisation and company insights. Morepen Laboratories Share Price pages on Univest help readers review the same verified metrics in one place and follow the stock as new market information appears.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply